{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:01:50Z","timestamp":1791295310923,"version":"4.1.0"},"reference-count":30,"publisher":"American Society of Hematology","issue":"17","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,4,25]]},"abstract":"<jats:title>Key Points<\/jats:title>\n                  <jats:p>IGH translocations in myeloma can occur through at least 5 mechanisms. t(11;14) and t(14;20) DH-JH rearrangement-mediated translocations occur indicating these appear to occur in a pregerminal center cell.<\/jats:p>","DOI":"10.1182\/blood-2012-12-471888","type":"journal-article","created":{"date-parts":[[2013,2,23]],"date-time":"2013-02-23T07:38:59Z","timestamp":1361605139000},"page":"3413-3419","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":148,"title":["Characterization of IGH locus breakpoints in multiple myeloma indicates a subset of translocations appear to occur in pregerminal center B cells"],"prefix":"10.1182","volume":"121","author":[{"given":"Brian A.","family":"Walker","sequence":"first","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Wardell","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin F.","family":"Kaiser","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dil B.","family":"Begum","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin B.","family":"Dahir","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona M.","family":"Ross","sequence":"additional","affiliation":[{"name":"Wessex Regional Genetics Laboratory, Salisbury District Hospital, Salisbury, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faith E.","family":"Davies","sequence":"additional","affiliation":[{"name":"Myeloma Targeted Treatment, Haemato-Oncology Research Unit, Divisions of Molecular Pathology, Cancer Therapeutics and Clinical Sciences, The Institute of Cancer Research, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gareth J.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Molecular Haematology, Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"6787","key":"2019111811270383800_B1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/35015097","article-title":"Frequent chromosomal translocations induced by DNA double-strand breaks.","volume":"405","author":"Richardson","year":"2000","journal-title":"Nature"},{"issue":"10","key":"2019111811270383800_B2","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma.","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"issue":"9","key":"2019111811270383800_B3","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1182\/blood-2007-02-069625","article-title":"Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma.","volume":"110","author":"Gonz\u00e1lez","year":"2007","journal-title":"Blood"},{"issue":"9","key":"2019111811270383800_B4","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","article-title":"Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation.","volume":"80","author":"Bakkus","year":"1992","journal-title":"Blood"},{"issue":"24","key":"2019111811270383800_B5","doi-asserted-by":"crossref","first-page":"13931","DOI":"10.1073\/pnas.93.24.13931","article-title":"Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myeloma.","volume":"93","author":"Bergsagel","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"2019111811270383800_B6","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1046\/j.1365-2141.1998.1161d.x","article-title":"True spectrum of 14q32 translocations in multiple myeloma.","volume":"103","author":"Pratt","year":"1998","journal-title":"Br J Haematol"},{"issue":"5","key":"2019111811270383800_B7","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma.","volume":"12","author":"Morgan","year":"2012","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"2019111811270383800_B8","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2141.2004.05050.x","article-title":"The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.","volume":"126","author":"Boersma-Vreugdenhil","year":"2004","journal-title":"Br J Haematol"},{"issue":"2","key":"2019111811270383800_B9","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1182\/blood.V88.2.674.bloodjournal882674","article-title":"Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.","volume":"88","author":"Chesi","year":"1996","journal-title":"Blood"},{"issue":"12","key":"2019111811270383800_B10","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood.V91.12.4457","article-title":"Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.","volume":"91","author":"Chesi","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2019111811270383800_B11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/ng0797-260","article-title":"Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.","volume":"16","author":"Chesi","year":"1997","journal-title":"Nat Genet"},{"issue":"9","key":"2019111811270383800_B12","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V92.9.3025.421k53_3025_3034","article-title":"The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH\/MMSET hybrid transcripts.","volume":"92","author":"Chesi","year":"1998","journal-title":"Blood"},{"issue":"3","key":"2019111811270383800_B13","doi-asserted-by":"crossref","first-page":"e32617","DOI":"10.1371\/journal.pone.0032617","article-title":"A modified method for whole exome resequencing from minimal amounts of starting DNA [published correction appears in PLoS One. 2012;7(4)].","volume":"7","author":"Kozarewa","year":"2012","journal-title":"PLoS ONE"},{"issue":"9","key":"2019111811270383800_B14","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.leu.2404304","article-title":"Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma.","volume":"20","author":"Chiecchio","year":"2006","journal-title":"Leukemia"},{"issue":"9","key":"2019111811270383800_B15","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2403857","article-title":"Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma.","volume":"19","author":"Ross","year":"2005","journal-title":"Leukemia"},{"key":"2019111811270383800_B16","author":"Brochet"},{"issue":"40","key":"2019111811270383800_B17","doi-asserted-by":"crossref","first-page":"5611","DOI":"10.1038\/sj.onc.1204641","article-title":"Chromosome translocations in multiple myeloma.","volume":"20","author":"Bergsagel","year":"2001","journal-title":"Oncogene"},{"issue":"14","key":"2019111811270383800_B18","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1182\/blood-2012-02-412791","article-title":"IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.","volume":"120","author":"Greisman","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2019111811270383800_B19","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1182\/blood-2002-06-1675","article-title":"In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression.","volume":"101","author":"Keats","year":"2003","journal-title":"Blood"},{"issue":"15","key":"2019111811270383800_B20","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1182\/blood-2010-04-279596","article-title":"A compendium of myeloma-associated chromosomal copy number abnormalities and their prognostic value.","volume":"116","author":"Walker","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111811270383800_B21","first-page":"1629","article-title":"Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma.","volume":"61","author":"Welzel","year":"2001","journal-title":"Cancer Res"},{"issue":"9","key":"2019111811270383800_B22","first-page":"1437","article-title":"Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster.","volume":"7","author":"Williams","year":"1993","journal-title":"Leukemia"},{"issue":"12","key":"2019111811270383800_B23","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"issue":"2","key":"2019111811270383800_B24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/leu.2011.204","article-title":"A novel prognostic model in myeloma based on co-segregating adverse FISH lesions and the ISS: analysis of patients treated in the MRC Myeloma IX trial.","volume":"26","author":"Boyd","year":"2012","journal-title":"Leukemia"},{"issue":"7","key":"2019111811270383800_B25","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3324\/haematol.2009.016329","article-title":"The t(14;20) is a poor prognostic factor in myeloma but is associated with long-term stable disease in monoclonal gammopathies of undetermined significance.","volume":"95","author":"Ross","year":"2010","journal-title":"Haematologica"},{"issue":"4","key":"2019111811270383800_B26","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/leu.2008.284","article-title":"MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.","volume":"23","author":"Stralen","year":"2009","journal-title":"Leukemia"},{"issue":"9","key":"2019111811270383800_B27","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1182\/blood-2007-02-075069","article-title":"Gene mapping and expression analysis of 16q loss of heterozygosity identifies WWOX and CYLD as being important in determining clinical outcome in multiple myeloma.","volume":"110","author":"Jenner","year":"2007","journal-title":"Blood"},{"issue":"20","key":"2019111811270383800_B28","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1073\/pnas.191175898","article-title":"WWOX: a candidate tumor suppressor gene involved in multiple tumor types.","volume":"98","author":"Paige","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111811270383800_B29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2006.10.003","article-title":"Large common fragile site genes and cancer.","volume":"17","author":"Smith","year":"2007","journal-title":"Semin Cancer Biol"},{"key":"2019111811270383800_B30","article-title":"A TC classification-based predictor for multiple myeloma using multiplexed real-time quantitative PCR [published online ahead of print January 15, 2013].","author":"Kaiser","journal-title":"Leukemia"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/17\/3413\/1364834\/3413.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/121\/17\/3413\/1364834\/3413.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T11:37:37Z","timestamp":1574077057000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/121\/17\/3413\/31231\/Characterization-of-IGH-locus-breakpoints-in"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,25]]},"references-count":30,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2013,4,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-12-471888","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717980637.793473412","asserted-by":"object"}]},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,25]]}}}